We invite people with increased cancer risks or positive tumour markers to order Rigvir SE now on www.smartnanovirus.com
Cancer virotherapy also is available via a new Telemedicine option. Everyone who has an approved oncology diagnosis can fill the application form to find out if Virotherapy can help in the current situation and the International Virotherapy Center patient service will find the nearest clinic who provides the remote treatment.
Unbelievable cancer patients survival story. They chose to live!
WATCH MOVIE NOW!
The story of the first oncolytic virus approved Read More
Virotherapy is an effective cancer treatment that uses oncotropic and oncolytic virus with the ability of a virus to find and destroy malignant cells in the body
Virotherapy is gentle and safe treatment, it improves survival and quality of life of patients
Every cancer patient has his story to tell. Here are some of them shared by our patents
Our support agents are here to answer your questions at any time. You can either e-mail us at firstname.lastname@example.org or leave your query on the website and we will contact you.
Oncolytic virus preclinical toxicology studies
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir
4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period
Clinical landscape of oncolytic virus research in 2020
The Oncolytic Virus in Cancer Diagnosis and Treatment
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir.
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumor in a retrospective study
© 2023 International Virotherapy Center Limited. All Rights Reserved